Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jaxon W Jordan, M.D.
- Phone Number: 325-370-2063
- Email: jwjordan@umc.edu
Study Contact Backup
- Name: Gina Jefferson, M.D.
- Phone Number: 3124339898
- Email: gjefferson@umc.edu
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- Recruiting
- University of Mississippi Medical Center
-
Contact:
- Gina Jefferson
- Phone Number: 312-433-9898
- Email: gjefferson@umc.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the exclusion criteria.
Exclusion Criteria:
- History of modified radical neck dissection involving removal of spinal accessory nerve or sternocleidomastoid muscle
- History of radical neck dissection
- History of pre- existing disabling shoulder complaints
- <18 years of age
- Any individual unable to provide consent for his/her self.
- Any individual with allergy, sensitivity, or aversion to porcine material.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Patients who provide consent for implant placement but do not receive the implant.
|
A porcine collagen implant will be used to make a protective sheath around the participant's exposed spinal accessory nerve during surgery.
This will be performed by physically wrapping the exposed nerve with the implant and suturing the ends together.
The goal is to protect nerve from adhesions and compression in the absence of normal protective lymphatic soft tissue.
|
|
Experimental: Interventional
Patients who provide consent for implant placement and do receive the implant.
|
A porcine collagen implant will be used to make a protective sheath around the participant's exposed spinal accessory nerve during surgery.
This will be performed by physically wrapping the exposed nerve with the implant and suturing the ends together.
The goal is to protect nerve from adhesions and compression in the absence of normal protective lymphatic soft tissue.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder function
Time Frame: The comparison of improvement or change in shoulder function over 6 months between the control and intervention groups will be the primary outcome measure.
|
Shoulder function will be assessed by Constant-Murley shoulder scale.
The Constant-Murley shoulder scale is a validated subjective and objective survey of overall shoulder function.
The scale ranges from 0 (no shoulder function) to 100 (perfect shoulder function).
It consists of several questions about pain and disability as well as actual shoulder testing that will be performed by the consenting physician during the participant's clinic appointment.
|
The comparison of improvement or change in shoulder function over 6 months between the control and intervention groups will be the primary outcome measure.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain following neck dissection: rate shoulder pain from 1-10
Time Frame: Patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
|
The comparison of the improvement or change in pain scores over 6 months between the control group and intervention group will be assessed at each clinical visit over the course of 6 months.
|
Patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2018-0212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.